High Incidence of Herpes Zoster in Patients with Systemic Lupus Erythematosus: an Immunological Analysis

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 1990 Aug 1

PMID 2168693

Citations 27

Authors

K Nagasawa

Y Yamauchi

Y Tada

T Kusaba

Y Niho

H Yoshikawa

Affiliations

Soon will be listed here.

Abstract

The incidence of herpes zoster was determined in patients with systemic lupus erythematosus (SLE) and the cellular and humoral immunity to varicella zoster virus (VZV) investigated in 45 of these 92 patients. The incidence of herpes zoster was high, occurring in 40 patients (43%), though it was benign in all. Patients with SLE who had had zoster showed significantly higher antibody titres than normal subjects. On the other hand, only 13 of 43 (30%) patients with SLE showed positive delayed hypersensitivity skin reactions to VZV antigen, despite a history of infections with VZV, whereas all 15 normal subjects had positive reactions. Skin reactions to VZV correlated directly with the ratio of OKT4+ to OKT8+ T cells and inversely with the dose of corticosteroids. These results suggest that the high incidence of herpes zoster in patients with SLE is probably due to defects in cellular immunity and that normal or higher titres of antibodies to VZV will not act as a preventive against zoster. In addition, reactivation of VZV, whether symptomatic or not, seemed often to occur in patients with SLE.

Citing Articles

Assessment of the humoral immune status of varicella-zoster virus in patients with diffuse connective tissue diseases.

Sun X, Zang Y, Xu Y, Wang W Front Med (Lausanne). 2024; 11:1470068.

PMID: 39301486 PMC: 11410609. DOI: 10.3389/fmed.2024.1470068.

Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine.

Ishihara R, Watanabe R, Shiomi M, Katsushima M, Fukumoto K, Yamada S Biomolecules. 2024; 14(7).

PMID: 39062454 PMC: 11274381. DOI: 10.3390/biom14070739.

Systematic Literature Review of Herpes Zoster Disease Burden in Southeast Asia.

San Martin P, Aunhachoke K, Batac M, Lodrono-Lim K, Kwanthitinan C, Santoso D Infect Dis Ther. 2023; 12(6):1553-1578.

PMID: 37314653 PMC: 10264888. DOI: 10.1007/s40121-023-00822-0.

Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.

Mok C, Ho L, Tse S, Chan K, To C Clin Rheumatol. 2022; 42(4):1019-1026.

PMID: 36385600 DOI: 10.1007/s10067-022-06450-2.

Herpes zoster in SLE: prevalence, incidence and risk factors.

Kwan A, Rayes H, Lazova T, Anderson N, Bonilla D, Su J Lupus Sci Med. 2022; 9(1).

PMID: 35017186 PMC: 8753438. DOI: 10.1136/lupus-2021-000574.

References

Hahn B, Bagby K, Osterland C . Abnormalities of delayed hypersensitivity in systemic lupus erythematosus. Am J Med. 1973; 55(1):25-31. DOI: 10.1016/0002-9343(73)90146-0. View

WELLER T . Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med. 1983; 309(22):1362-8. DOI: 10.1056/NEJM198312013092205. View

DUBOIS E, Tuffanelli D . CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964; 190:104-11. DOI: 10.1001/jama.1964.03070150014003. View

Hamaguchi T, Kotani Y, IMANAKA S, MORITO S, Kawamura Y . Lupus erythematosus and herpes zoster. Mie Med J. 1970; 19(3):189-92. View

Ginzler E, Diamond H, KAPLAN D, Weiner M, Schlesinger M, Seleznick M . Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 1978; 21(1):37-44. DOI: 10.1002/art.1780210107. View

BURGOON Jr C, BURGOON J, Baldridge G . The natural history of herpes zoster. J Am Med Assoc. 1957; 164(3):265-9. DOI: 10.1001/jama.1957.02980030041010. View

Arvin A, Pollard R, Rasmussen L, Merigan T . Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. J Clin Invest. 1980; 65(4):869-78. PMC: 434474. DOI: 10.1172/JCI109739. View

Hope-Simpson R . THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med. 1965; 58:9-20. PMC: 1898279. View

Dolin R, Reichman R, Mazur M, Whitley R . NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978; 89(3):375-88. DOI: 10.7326/0003-4819-89-3-375. View

10.

Burke B, Steele R, BEARD O, Wood J, Cain T, Marmer D . Immune responses to varicella-zoster in the aged. Arch Intern Med. 1982; 142(2):291-3. View

11.

Cupps T, Edgar L, Thomas C, Fauci A . Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. J Immunol. 1984; 132(1):170-5. View

12.

UNANUE E . The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. Adv Immunol. 1981; 31:1-136. DOI: 10.1016/s0065-2776(08)60919-0. View

13.

Sever J . Application of a microtechnique to viral serological investigations. J Immunol. 1962; 88:320-9. View

14.

Moutsopoulos H, Gallagher J, Decker J, Steinberg A . Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum. 1978; 21(7):798-802. DOI: 10.1002/art.1780210710. View

15.

Kamiya H, Ihara T, Hattori A, Iwasa T, Sakurai M, Izawa T . Diagnostic skin test reactions with varicella virus antigen and clinical application of the test. J Infect Dis. 1977; 136(6):784-8. DOI: 10.1093/infdis/136.6.784. View

16.

Bakke A, Kirkland P, Kitridou R, Quismorio Jr F, Rea T, Ehresmann G . T lymphocyte subsets in systemic lupus erythematosus. Correlations with corticosteroid therapy and disease activity. Arthritis Rheum. 1983; 26(6):745-50. DOI: 10.1002/art.1780260607. View

17.

WELLER T . Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N Engl J Med. 1983; 309(23):1434-40. DOI: 10.1056/NEJM198312083092306. View

18.

Smolen J, Chused T, Leiserson W, Reeves J, Alling D, Steinberg A . Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features. Am J Med. 1982; 72(5):783-90. DOI: 10.1016/0002-9343(82)90544-7. View

19.

Mazur M, Whitley R, Dolin R . Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979; 139(12):1341-5. View

20.

WRIGHT E, WINER L . Herpes zoster and malignancy. Arch Dermatol. 1961; 84:242-4. DOI: 10.1001/archderm.1961.01580140068007. View